1.8706
price down icon4.62%   -0.0794
 
loading
Schlusskurs vom Vortag:
$1.95
Offen:
$1.9
24-Stunden-Volumen:
121.28K
Relative Volume:
0.13
Marktkapitalisierung:
$24.80M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-7.51M
KGV:
-1.4171
EPS:
-1.32
Netto-Cashflow:
$-8.02M
1W Leistung:
-3.12%
1M Leistung:
+48.82%
6M Leistung:
+78.85%
1J Leistung:
+108.43%
1-Tages-Spanne:
Value
$1.83
$1.9239
1-Wochen-Bereich:
Value
$1.75
$2.115
52-Wochen-Spanne:
Value
$0.6506
$3.80

Hoth Therapeutics Inc Stock (HOTH) Company Profile

Name
Firmenname
Hoth Therapeutics Inc
Name
Telefon
(646)756-2997
Name
Adresse
1177 AVENUE OF THE AMERICAS, NEW YORK, NY
Name
Mitarbeiter
3
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-11
Name
Neueste SEC-Einreichungen
Name
HOTH's Discussions on Twitter

Vergleichen Sie HOTH mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
HOTH
Hoth Therapeutics Inc
1.8706 27.45M 0 -7.51M -8.02M -1.32
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
381.70 97.36B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
575.45 60.19B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
455.65 59.56B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
718.08 44.94B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
331.00 36.14B 3.81B -644.79M -669.77M -6.24

Hoth Therapeutics Inc Stock (HOTH) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2019-10-15 Eingeleitet The Benchmark Company Speculative Buy

Hoth Therapeutics Inc Aktie (HOTH) Neueste Nachrichten

pulisher
Sep 24, 2025

Hoth expands HT-001 development with patents for cancer therapy side effects - Investing.com India

Sep 24, 2025
pulisher
Sep 24, 2025

Hoth Therapeutics Expands Patent Portfolio for HT-001 to Target Wider Range of Skin Toxicities - MarketScreener

Sep 24, 2025
pulisher
Sep 24, 2025

Novel Drug Could Help Cancer Patients Stay on Life-Saving Treatments: Hoth's HT-001 Targets Multiple Skin Effects - Stock Titan

Sep 24, 2025
pulisher
Sep 23, 2025

Hoth Therapeutics, Inc. (HOTH) Files EMA Application for Global Expansion of HT-001 Skin Therapy - Yahoo Finance

Sep 23, 2025
pulisher
Sep 20, 2025

Chart Watch: Can Hoth Therapeutics Inc stock double in the next year2025 Trade Ideas & Community Verified Watchlist Alerts - خودرو بانک

Sep 20, 2025
pulisher
Sep 19, 2025

Bull Run: Will Hoth Therapeutics Inc benefit from rising consumer demandMarket Performance Report & Risk Controlled Stock Pick Alerts - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

New Highs: Whats the MACD signal for Hoth Therapeutics IncWeekly Trend Recap & Proven Capital Preservation Tips - خودرو بانک

Sep 19, 2025
pulisher
Sep 18, 2025

Risks Report: Whats the outlook for Hoth Therapeutics Incs sectorWeekly Trading Summary & Daily Price Action Insights - خودرو بانک

Sep 18, 2025
pulisher
Sep 18, 2025

Market Review: Is NGVT a momentum stockMarket Weekly Review & Risk Controlled Swing Alerts - khodrobank.com

Sep 18, 2025
pulisher
Sep 18, 2025

Is Hoth Therapeutics Inc benefiting from innovation trendsEarnings Recap Report & Real-Time Volume Surge Alerts - خودرو بانک

Sep 18, 2025
pulisher
Sep 18, 2025

Market Outlook: Will Hoth Therapeutics Inc. announce a stock splitQuarterly Profit Summary & Advanced Swing Trade Entry Alerts - خودرو بانک

Sep 18, 2025
pulisher
Sep 18, 2025

Aug Shorts: How correlated is Hoth Therapeutics Inc to the S P500July 2025 Big Picture & Expert Verified Movement Alerts - خودرو بانک

Sep 18, 2025
pulisher
Sep 17, 2025

Risk Analysis: What are the future prospects of NEEPRTTrade Ideas & Real-Time Sentiment Analysis - خودرو بانک

Sep 17, 2025
pulisher
Sep 16, 2025

Take Profit: Will Hoth Therapeutics Inc benefit from rising consumer demand2025 Risk Factors & High Conviction Buy Zone Picks - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Risk Hedge: Is Monster Beverage Corporation a defensive stockProduct Launch & Daily Risk Controlled Trade Plans - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Hoth Therapeutics issues update- HT-001, HT-KIT, VA Obesity Program drive strongest position in company history - MarketScreener

Sep 16, 2025
pulisher
Sep 16, 2025

Hoth Therapeutics Issues Shareholder Update: HT-001, HT-KIT, Expanded Treasury Reserve Strategy, and VA Obesity Program Drive Strongest Position in Company History - PR Newswire

Sep 16, 2025
pulisher
Sep 16, 2025

Support Test: What is the dividend yield of Hoth Therapeutics Inc2025 Biggest Moves & Entry Point Confirmation Signals - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

$1M Crypto Treasury Plan: Hoth Therapeutics Expands Global Trial Network While Adding Bitcoin Strategy - Stock Titan

Sep 16, 2025
pulisher
Sep 15, 2025

Risk Off: What is Hoth Therapeutics Inc. s debt to equity ratioJuly 2025 Price Swings & Advanced Swing Trade Entry Plans - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

What MACD and RSI say about Hoth Therapeutics Inc.July 2025 Drop Watch & Weekly Watchlist for Consistent Profits - newser.com

Sep 15, 2025
pulisher
Sep 15, 2025

Will Hoth Therapeutics Inc. announce a stock splitMarket Trend Report & Weekly Consistent Profit Watchlists - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Stock Report: What is the dividend yield of Hoth Therapeutics IncCPI Data & Trade Opportunity Analysis Reports - خودرو بانک

Sep 15, 2025
pulisher
Sep 12, 2025

Hoth Therapeutics climbs on $1 million crypto reserve plan - TradingView

Sep 12, 2025
pulisher
Sep 12, 2025

Hoth Therapeutics climbs on $1 mln crypto reserve plan - TradingView

Sep 12, 2025
pulisher
Sep 12, 2025

Hoth Therapeutics approved expansion of treasury reserve strategy to include Ethereum and Solana - MarketScreener

Sep 12, 2025
pulisher
Sep 10, 2025

Hoth Therapeutics Announces Positive Findings on GDNF's Potential as a Game-Changer in Obesity Treatment and Reduced Fatty Liver Disease - 富途牛牛

Sep 10, 2025
pulisher
Sep 10, 2025

Hoth Therapeutics submits European application for skin toxicity drug - Investing.com

Sep 10, 2025
pulisher
Sep 10, 2025

Hoth Therapeutics submits European application for skin toxicity drug By Investing.com - Investing.com Nigeria

Sep 10, 2025
pulisher
Sep 10, 2025

Hoth Therapeutics reaches EMA milestone for HT-001 phase II trial targeting EGFRi-linked skin toxicities - MarketScreener

Sep 10, 2025
pulisher
Sep 10, 2025

Hoth Therapeutics Secures Key European Regulatory Milestone with EMA Submission for Phase II Trial of HT-001 in Cancer Patients Suffering from EGFRi-Induced Skin Toxicities - WV News

Sep 10, 2025
pulisher
Sep 09, 2025

3 Under-the-Radar Biotechs Under $5 That Could Soar 200% - MarketBeat

Sep 09, 2025
pulisher
Sep 08, 2025

Chart Analysts Warn of Resistance Near Hoth Therapeutics Inc. PriceJuly 2025 Market Mood & Capital Efficiency Focused Ideas - beatles.ru

Sep 08, 2025
pulisher
Sep 07, 2025

How does Hoth Therapeutics Inc. correlate with NasdaqWeekly Trend Summary & High Win Rate Trade Tips - classian.co.kr

Sep 07, 2025
pulisher
Sep 06, 2025

Earnings visualization tools for Hoth Therapeutics Inc.2025 Stock Rankings & Expert Approved Momentum Ideas - Newser

Sep 06, 2025
pulisher
Sep 05, 2025

Can Hoth Therapeutics Inc. stock double in the next year2025 Earnings Impact & Stepwise Trade Signal Guides - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

Published on: 2025-09-06 01:25:14 - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

Hoth Therapeutics shares fall 2.24% premarket after adopting Lantern Pharma's AI-driven drug development tool. - AInvest

Sep 05, 2025
pulisher
Sep 05, 2025

Is Hoth Therapeutics Inc. building a consolidation basePortfolio Profit Report & Weekly Hot Stock Watchlists - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Is Hoth Therapeutics Inc. trending in predictive chart modelsPortfolio Update Summary & Reliable Intraday Trade Plans - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Hoth Therapeutics adopts AI platform to advance drug development By Investing.com - Investing.com Canada

Sep 05, 2025
pulisher
Sep 04, 2025

Is Hoth Therapeutics Inc. a momentum stockRate Cut & Risk Managed Investment Entry Signals - خودرو بانک

Sep 04, 2025
pulisher
Sep 04, 2025

Hoth Therapeutics adopts AI platform to advance drug development - Investing.com India

Sep 04, 2025
pulisher
Sep 04, 2025

Hoth Therapeutics shares fall 1.49% after-hours after adopting Lantern Pharma's AI-driven drug development tool. - AInvest

Sep 04, 2025
pulisher
Sep 04, 2025

What indicators show strength in Hoth Therapeutics Inc.Dividend Hike & Real-Time Stock Movement Alerts - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Lantern Pharma shares fall 1.52% intraday after FDA meeting and Hoth Therapeutics partnership. - AInvest

Sep 04, 2025
pulisher
Sep 04, 2025

Using AI based signals to follow Hoth Therapeutics Inc.2025 Momentum Check & Free Community Consensus Stock Picks - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

AI-Driven Drug Development: Hoth Therapeutics and Lantern Pharma’s Strategic Partnership to Revolutionize CNS Therapies - AInvest

Sep 04, 2025
pulisher
Sep 04, 2025

Lantern Pharma's PredictBBB.ai Platform to Drive Next-Gen Drug Development with Hoth Therapeutics Partnership - AInvest

Sep 04, 2025
pulisher
Sep 04, 2025

Hoth Therapeutics Taps Lantern Pharma's PredictBBB.ai Platform -- Breakthrough AI With 94% Accuracy Driving Next-Gen Drug Development - PR Newswire

Sep 04, 2025
pulisher
Sep 04, 2025

Is Hoth Therapeutics Inc. benefiting from innovation trendsWeekly Profit Analysis & Smart Investment Allocation Tips - خودرو بانک

Sep 04, 2025

Finanzdaten der Hoth Therapeutics Inc-Aktie (HOTH)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$35.72
price down icon 0.23%
$83.24
price down icon 1.06%
$29.29
price down icon 0.78%
$98.88
price down icon 0.70%
$139.51
price down icon 0.64%
biotechnology ONC
$330.97
price up icon 0.33%
Kapitalisierung:     |  Volumen (24h):